A potentially groundbreaking meta-analysis of 176 studies was published earlier this year in the Cochrane Database of Systematic Reviews that assessed individual antidepressant medications and whether they proved effective in treating chronic pain in…
There are signs that the supply chain issues we’ve all witnessed over the past several years have started to subside, offering relief to many. That said, the pharmaceutical industry isn’t entirely out of the woods just yet. Supply chain setbacks have…
Our pharmacists speak out on the use of hydroxychloroquine as an emerging treatment option and appropriate clinical guidance during the coronavirus (COVID-19) outbreak During the past several weeks, our pharmacy program team has been working to ensu…
My recent curbing compounding post outlined Texas’ regulatory response to the alarming rise in use and cost for compound prescription drugs and the legislation being put in place to curb compounding within the state. While this marks a cont…
With its new rule requiring preauthorization of compound prescription drugs, Texas has become the latest state to attempt to curb the unnecessary use of compound drugs in workers’ compensation. The Texas Division of Workers’ Compensation (DWC) drafte…
Claims administrators have an invaluable opportunity to help future pharmacists understand the challenges regarding prescription drug use for occupational injuries. A pharmacist intern program, like the one we offer at Sedgwick, can provide ex…
As we move into the new year, I am excited about all the great things I believe will happen in our industry. Taking care of people is at the heart of everything we do at Sedgwick – from ensuring injured and ill workers have access to the right heal…